Janet Hopkins
Technik-/Wissenschafts-/F&E-Leiter bei AURA BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Elisabet de los Pinos | M | 51 | 17 Jahre | |
Raj Bhikhu Parekh | M | 63 | 9 Jahre | |
Daniel Hochstrasser | M | 64 | 2 Jahre | |
John Young | M | 60 | 1 Jahre | |
Ana de Pro Gonzalo | F | 57 | 2 Jahre | |
Karan Takhar | M | 32 | 3 Jahre | |
Giovanni Mariggi | M | 39 | 5 Jahre | |
Antony Mattessich | M | 57 | 3 Jahre | |
David Johnson | M | 59 | 3 Jahre | |
Sapna R. Srivastava | M | 53 | 3 Jahre | |
Alex Dasalla | M | - | 2 Jahre | |
Edward Lang | M | 44 | 5 Jahre | |
Amy Elazzouzi | F | - | - | |
Chinmay Umesh Bhatt | M | 51 | - | |
Carrie Murray | M | - | - | |
Ian Pitfield | M | 58 | 4 Jahre | |
Julie Feder | F | 54 | 6 Jahre | |
Jane Hughes | M | 50 | 5 Jahre | |
Joseph Lyons | M | - | 3 Jahre | |
Jason Mark Brooks | M | 52 | - | |
Shreeram Aradhye | M | 62 | 2 Jahre | |
Mark Plavsic | M | 63 | 1 Jahre | |
Aharon Gal | M | 58 | 2 Jahre | |
Anthony Adamis | M | 65 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 3 Jahre |
Kees Roks | M | 61 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
John Tsai | M | 57 | 4 Jahre | |
Eric Boutin | M | - | 3 Jahre | |
Seshu Tyagarajan | M | 57 | 2 Jahre | |
Maha Katabi | M | 50 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 1 Jahre |
Chris Hollowood | M | 50 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 6 Jahre |
Renée Galá | F | 52 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 2 Jahre |
Elizabeth Theophille | F | 57 | 7 Jahre | |
Cadmus Rich | M | 59 | 6 Jahre | |
Dominic Schmidt | M | 42 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 3 Jahre |
Marie-France Tschudin | F | 53 | 1 Jahre | |
Natacha Theytaz | M | - | 4 Jahre | |
Paulo Carvalho | M | - | 3 Jahre | |
Lutz Hegemann | M | 58 | - | |
Amy Wolf | F | - | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 15 | 38,46% |
Schweiz | 14 | 35,90% |
Vereinigtes Königreich | 10 | 25,64% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Janet Hopkins
- Persönliches Netzwerk